| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ffbe71cb54b92414ad178bb647126c1d |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-48 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-714
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-195
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-197
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-137 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-195
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-197
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-714
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-08 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-137 |
| filingDate |
2019-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8772adbbe9fa39d5ee440f88b3f24043
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7da5d9e0e7da7dba2aa37680b9bc5a85
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c67cc6c3aded41f52d3986b2fcde2da7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5c1c72a26d31c63580b2959eb9428aeb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_de9fcb8cecbef06dc47cf1cbce0bd235
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f1565717bed0432d27b8e4f446914df1 |
| publicationDate |
2020-06-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2019245512-A3 |
| titleOfInvention |
A combination comprising fingolimod and at least one anti-epileptic agent |
| abstract |
The present invention relates to a pharmaceutical combination comprising fingolimod or a pharmaceutically acceptable salt thereof and at least one anti-epileptic agent. |
| priorityDate |
2018-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |